Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

Abstract

IRF5 mediates the inflammatory responses in the CNS, which might serve as a therapeutic target for CNS inflammatory diseases. LPS-induced inflammation does not involve IRF5 signaling in BV2 microglia.